NIAID NewsVerified account

@NIAIDNews

National Institute of Allergy and Infectious Diseases (NIAID), NIH. Following and followers does not equal endorsement. Privacy policy:

Bethesda, MD
niaid.nih.gov
Joined July 2009
1,321 Photos and videos Photos and videos

Tweets

You blocked @NIAIDNews

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @NIAIDNews

  1. Retweeted
    Apr 5

    Is safe for clinical use as an anti-infective? A new report sheds some light on this question by offering suggestions from ’s Taskforce. Read more:

    1 reply 5 retweets 13 likes
    Undo
  2. Apr 7

    TB NEWS: lays TRACs—new awards to establish Research Advancement Centers. The awards will foster development of a new generation of researchers at 4 centers nationwide.

    Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAID
    5 retweets 11 likes
    Undo
  3. Retweeted
    Apr 6

    Funding News . Learn about NIH partnerships with Tribal Nations, three new G11 sample applications, peer review of SBIR applications, recent FOAs, and more!

    2 retweets 2 likes
    Undo
  4. Apr 6

    FLU NEWS: Neuraminidase (NA) is a surface protein on viruses, a potential target for new flu . A paper from NIAID and reports the structural stabilization of NA to advance NA-based vaccine design:

    5 retweets 8 likes
    Undo
  5. Apr 5

    🙋 The is looking for healthy ages 18-29 in the DC area to screen for an investigational vaccine clinical trial. Financial compensation will be provided for screening visits.

    2 replies 3 retweets 11 likes
    Undo
  6. Retweeted
    Apr 4

    The latest issue of Pathways magazine is out now! Learn about the science behind mRNA vaccines and how researchers were equipped to respond to COVID-19.

    3 replies 11 retweets 19 likes
    Show this thread
    Show this thread
    Undo
  7. Apr 1

    NEWS: In a new commentary in The Journal of Infectious Diseases, experts discuss how COVID-19 can still be prevented and controlled, even if herd immunity may not be attainable. Learn more:

    2 replies 5 retweets 7 likes
    Undo
  8. Mar 31

    COVID19 NEWS: NIAID’s SAVE program, an “Avengers-Like” approach to research for evolving pathogens , draws on scientists from around the world who specialize in various research areas to quickly assess new variants. Read more:

    3 replies 4 retweets 9 likes
    Undo
  9. Mar 31

    The trial will adapt to evaluate additional vaccine platforms and variant vaccines from other manufacturers.

    1 retweet 4 likes
    Show this thread
    Show this thread
    Undo
  10. Mar 31

    The trial initially aims to enroll 600 adults at 24 sites in the U.S. The study vaccines are manufactured by and include the prototype Spikevax as well as investigational vaccines targeting the Omicron, Delta and Beta variants.

    1 reply 1 retweet 7 likes
    Show this thread
    Show this thread
    Undo
  11. Mar 31

    COVID-19 NEWS: has begun a clinical trial which aims to understand if different vaccine boosts—prototype & variant vaccines alone & in combinations—can broaden immune responses. The results will inform future booster shot recommendations.

    5 replies 11 retweets 39 likes
    Show this thread
    Show this thread
    Undo
  12. Retweeted
    Mar 25

    Failure to follow the instructions may result in an inaccurate test result. Watch this video from to learn how to correctly self-test at home:  

    3 replies 16 retweets 33 likes
    Undo
  13. Mar 30

    NEWS: A NIAID-supported trial to evaluate an new experimental vaccine for bacterial in young children has begun in Mali. Learn more in this release from :

    3 likes
    Undo
  14. Mar 29

    consists of long-acting formulations of the antiretroviral drugs & given as two injections once every other month or monthly. For some adolescents living with , adhering to this treatment regimen may be easier than taking daily pills.

    1 retweet 5 likes
    Show this thread
    Show this thread
    Undo
  15. Mar 29

    This approval is based on drug level and safety data from an ongoing -supported clinical trial of in 12- to 17-year-olds living with .

    1 reply 1 retweet 4 likes
    Show this thread
    Show this thread
    Undo
  16. Mar 29

    HIV News: Today celebrates the first approval extending the lower age limit of a long-acting treatment regimen, ’s , to adolescents ages 12 to 17 years.

    1 reply 16 retweets 34 likes
    Show this thread
    Show this thread
    Undo
  17. Retweeted
    Mar 22

    Join us for a webinar on 3/29 at 3:30 pm ET to learn more about the background, planning process, and draft framework for ’s Strategic Plan for diversity, equity, inclusion, and accessibility ():

    2 replies 45 retweets 42 likes
    Undo
  18. Retweeted
    Mar 23

    supports studies of test performance through the Tech program. Data show that authorized tests detect at a similar rate as other variants. Find updated info on variant impact on tests from :

    7 replies 20 retweets 33 likes
    Undo
  19. Mar 24

    NIAID supports research for promising new TB interventions. Read more about the research at

    2 replies 1 retweet 6 likes
    Show this thread
    Show this thread
    Undo
  20. Mar 24

    March 24 is World Tuberculosis (TB) Day. TB is the second leading infectious killer in the world after COVID-19. During the coronavirus pandemic, reduced access to care interrupted TB control, resulting in more deaths.

    Text reads "Tuberculosis (TB) is the second leading infectious killer in the world, after COVID-19." An image of TB shows up behind the text.
    1 reply 20 retweets 56 likes
    Show this thread
    Show this thread
    Undo

@NIAIDNews hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·